Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 14, 2017
Patent Application Number
13774349
Date Filed
February 22, 2013
Patent Citations Received
Patent Primary Examiner
Patent abstract
Modified relaxin polypeptides and their uses, including therapeutic uses thereof for the treatment of a fibrotic disorder or heart failure are provided. Exemplary embodiments provide for the use of relaxin polypeptides which include one or more amino acid substitutions with natural or non-naturally encoded amino acids, and/or linkage to a water-soluble polymer, such as polyethylene glycol.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
